Compiled with the advice of clinical experts and continually updated to reflect the latest evidence from credible sources worldwide, the new edition of the British National Formulary 84 (BNF) provides up-to-date guidance on prescribing, dispensing, and administering medicines. Access to the latest edition of the BNF is vital for healthcare professionals, as it reflects current best practice as well as legal and professional guidelines relating to the uses of medicines. NICE has accredited the editorial process used by the British National Formulary to produce its resources.

Extensive content updates in the BNF 84 edition include:

New Monographs added on

• Renoxitin® [cefoxitin] for complicated urinary tract infections and pyelonephritis
• Ledaga® gel [chlormethine] for mycosis fungoides
• Ondexxya® [andexanet alfa] for reversal of apixaban or rivaroxaban in life-threatening or uncontrolled bleeding
• Epidyolex® [cannabidiol] for seizures associated with Lennox-Gastaut syndrome and seizures associated with Dravet syndrome [adjunctive treatment with clobazam]
• Rizmoic® [naldemedine] for opioid-induced constipation.

MHRA advice on
• Febuxostat (Adenuric®): increased risk of cardiovascular death and all-cause mortality in clinical trial in patients with a history of major cardiovascular disease
• Pentosan polysulfate sodium (Elmiron®): rare risk of pigmentary maculopathy
• Hormone replacement therapy (HRT) (conjugated oestrogens (equine) and estradiol): further information on the known increased risk of breast cancer with HRT and its persistence after stopping.

Dose changes including Magnesium sulfate: Change to additional dose for seizure recurrence in pre-eclampsia and eclampsia.
Updated guidance on Vaccines in-line with Public Health England recommendations

• Language ‏ : ‎ English
• Paperback ‏ : ‎ 1864 pages
• ISBN-10 ‏ : ‎ 0857114328
• ISBN-13 ‏ : ‎ 978-۰۸۵۷۱۱۴۳۲۷
• Item Weight ‏ : ‎ 2.۴ pounds
• Dimensions ‏ : ‎ 6 x 1.75 x 8.25 inches
• # Pharmacology (Books)